↓ Skip to main content

A master protocol to investigate a novel therapy acetyl-l-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 gangliosidoses, and ataxia telangiectasia

Overview of attention for article published in Trials, January 2021
Altmetric Badge

Mentioned by

twitter
2 X users
wikipedia
1 Wikipedia page

Readers on

mendeley
63 Mendeley